Putnam Valley, NY, United States of America

Joel H Martin

This inventor holds 61 USPTO granted patents and 22 published patent applications, plus 9 CIPO patents and 16 EPO patents, primarily in Monoclonal Antibodies (CPC class C07K). Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2009-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Joel H Martin. Retrieved from https://idiyas.com/inventor/joel-h-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 61 (Patent Applications = 22)

% Patents Active = 95.1

CIPO Patents = 9

EPO Patents = 16 (Patent Applications = 19)

Average Co-Inventor Count = 5.7

ph-index = 20

Forward Citations = 1,338(Granted Patents)

Forward Citations (Not Self Cited) = 1,239(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Putnam Valley, NY (US) (2009 - 2023)
Tarrytown, NY (US) (2023)

Company Filing History:

59 out of 1,482

Regeneron Pharmaceuticals, Inc.

patents

2 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2009-2026

Loading Chart...

Areas of Expertise:

pH-Sensitive Immunoglobulin

Multispecific Antibodies

Anti-PCSK9

VEGF Traps

Osteoarthritis Treatment

Human IL-6 Receptor

Anti-EGFRvIII

Rheumatoid Arthritis

Human IL-4 Receptor

B-cell Lymphoma

Nerve Growth Factor

61 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12680107 - NON-HUMAN ANIMALS COMPRISING A HUMANIZED ASGR1 LOCUS (2026-07-14),

2. 12543711 - Non-Human Animals Expressing pH-Sensitive Immunoglobulin Sequences (2026-02-10),

3. 12297257 - Multispecific antigen-binding molecules and uses thereof (2025-05-13),

4. 12269897 - Anti-PCSK9 antibodies (2025-04-08),

5. 12162943 - High affinity human antibodies to human IL-4 receptor (2024-12-10),

6. 12103960 - VEGF traps and mini-traps and methods for treating ocular disorders and cancer (2024-10-01),

7. 11820815 - Human antibodies to human delta like ligand 4 (2023-11-21),

8. 11696572 - Non-human animals comprising a humanized ASGR1 locus (2023-07-11),

9. 11608380 - Anti-EGFRvIII antibodies and uses thereof (2023-03-21),

10. 11518804 - Method of treating osteoarthritis with an antibody to NGF (2022-12-06),

11. 11370843 - High affinity antibodies to human IL-6 receptor (2022-06-28),

12. 11224207 - Non-human animals expressing pH-sensitive immunoglobulin sequences (2022-01-18),

13. 11191844 - Multispecific antigen-binding molecules and uses thereof (2021-12-07),

14. 11129903 - Multispecific antigen-binding molecules and uses thereof (2021-09-28),

15. 10941210 - Anti-PCSK9 antibodies (2021-03-09),

Title: The Innovative Mind of Joel H Martin

Introduction: Joel H Martin, a talented inventor hailing from Putnam Valley, NY, has made significant contributions to the world of innovations with his creative thinking and problem-solving skills.

Latest Patents: Joel H Martin holds several patents in various fields, including technology, healthcare, and consumer products. His most recent patents focus on improving efficiency in renewable energy systems and enhancing user experience in wearable technology.

Career Highlights: Throughout his career, Joel H Martin has demonstrated a keen ability to identify gaps in the market and develop groundbreaking solutions to address them. His innovative approach has led to the successful commercialization of several products that have positively impacted industries and consumers alike.

Collaborations: Joel H Martin has collaborated with leading research institutions, universities, and companies to bring his ideas to life. These collaborations have not only accelerated the development process but have also allowed for the integration of cutting-edge technologies into his inventions.

Conclusion: Joel H Martin's passion for innovation, coupled with his dedication to pushing the boundaries of what is possible, continues to inspire the next generation of inventors. His contributions to the field of inventions have left a lasting impact, shaping the way we live and interact with technology.

Profile summary based on public USPTO records.